Page last updated: 2024-11-06

sulfluramid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Sulfluramid is a sulfonamide derivative that has been investigated as a potential anticonvulsant and anxiolytic agent. Its synthesis involves a reaction between an aromatic amine and a sulfonyl chloride. Research suggests that sulfluramid may exert its effects by modulating the activity of GABAergic neurotransmission. However, despite showing promise in preclinical studies, sulfluramid has not been widely studied or commercialized due to concerns regarding its potential toxicity and limited efficacy. The compound has been studied as a potential treatment for epilepsy and anxiety disorders, but further research is needed to determine its clinical utility.'

sulfluramid: delayed-action insecticide against the cockroach Dyctyoptera; Blattelidae germanica [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

sulfluramid : A sulfonamide obtained by the formal condensation of perfluorooctane-1-sulfonic acid with ethylamine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID77797
CHEMBL ID177726
CHEBI ID81945
SCHEMBL ID26873
MeSH IDM0175825

Synonyms (60)

Synonym
unii-ipx089yr0a
ipx089yr0a ,
sulfluramid [ansi:iso]
hsdb 7100
brn 2317462
einecs 223-980-3
sulfluramid
n-ethylperfluorooctanesulfonamide
mirex s
sulfluramid [iso]
finitron
epa pesticide chemical code 128992
ai 3-29757
gx 071
n-ethylperfluorooctylsulfonamide
alstar (pesticide)
gx-071
n-ethylheptadecafluorooctanesulphonamide
1-octanesulfonamide, n-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-
ai3-29757
n-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-1-octanesulfonamide
NCGC00164466-01
4151-50-2
chebi:81945 ,
CHEMBL177726
n-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonamide
NCGC00164466-02
AKOS007930417
C18766
dtxsid1032646 ,
NCGC00254305-01
dtxcid9012646
tox21_300377
cas-4151-50-2
A825576
n-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecakis(fluoranyl)octane-1-sulfonamide
n-ethyl perfluoro octanesulphonamide
FT-0635156
SCHEMBL26873
sulfiuramid
n-ethyl perfluorooctyl sulphonamide
c8f17so2n(c2h5)h
perfluorooctylsulfonic acid-n-ethylamide
n-ethylperfluorooctane-1-sulfonamide
sulfluramid [hsdb]
volcano (insecticide)
n-ethyl perfluorooctanesulphonamide
Q-201766
ethyl perfluorooctylsulfonamide
n-ethyl perfluorooctylsulfonamide
sulfluramid, analytical standard
n-ethyl perfluorooctylsulphonamide
mfcd00042274
ES-2017
n-ethyl perfluoro-octane-1-sulfonamide
n-etfosa
etfosa
Q15632828
netfosa
E80385

Research Excerpts

Overview

Sulfluramid is an expensive active principle of insecticidal baits that is lost by volatilization during the pelletization of baits.

ExcerptReferenceRelevance
"Sulfluramid is an expensive active principle of insecticidal baits that is lost by volatilization during the pelletization of baits. "( Sulfluramid volatility reduction by beta-cyclodextrin.
Bergamasco, Rde C; de Moraes, FF; Zanin, GM, 2005
)
3.21

Toxicity

The LD50 of sulfluramid topically applied to 2-d-old, fifth instars of the German cockroach, Blattella germanica (L.G.) was 175.

ExcerptReferenceRelevance
" The topical LD50 of sulfluramid was 175."( Toxicity, sublethal effects, and performance of sulfluramid against the German cockroach (Dictyoptera: Blattellidae).
Abd-Elghafar, SF; Appel, AG, 1990
)
0.85
"The LD50 of sulfluramid topically applied to 2-d-old, fifth instars of the German cockroach, Blattella germanica (L."( Topical and oral toxicity of sulfluramid, a delayed-action insecticide, against the German cockroach (Dictyoptera: Blattellidae).
Barcay, SJ; Bennett, GW; Reid, BL, 1990
)
0.95

Dosage Studied

ExcerptRelevanceReference
"The objectives of this study were to characterize the absorption, distribution, and elimination of sulfluramid (N-ethyl perfluorooctane sulfonamide) and its major metabolite, perfluorooctane sulfonamide (DESFA), in order to assess the effect of dosage vehicle on their pharmacokinetics."( Metabolism and disposition of sulfluramid, a unique polyfluorinated insecticide, in the rat.
Bowen, JM; Bruckner, JV; Manning, RO; Mispagel, ME,
)
0.64
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
environmental contaminantAny minor or unwanted substance introduced into the environment that can have undesired effects.
xenobioticA xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means.
acaricideA substance used to destroy pests of the subclass Acari (mites and ticks).
insecticideStrictly, a substance intended to kill members of the class Insecta. In common usage, any substance used for preventing, destroying, repelling or controlling insects.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
sulfonamideAn amide of a sulfonic acid RS(=O)2NR'2.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (11)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency38.40180.000714.592883.7951AID1259369; AID1259392
progesterone receptorHomo sapiens (human)Potency65.67060.000417.946075.1148AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency10.50380.000214.376460.0339AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency65.67060.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency46.91860.000817.505159.3239AID1159527
farnesoid X nuclear receptorHomo sapiens (human)Potency0.03160.375827.485161.6524AID588527
estrogen nuclear receptor alphaHomo sapiens (human)Potency11.19280.000229.305416,493.5996AID743075; AID743078
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency4.14350.001723.839378.1014AID743083
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency59.067019.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency59.06700.057821.109761.2679AID1159526
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency22.03380.000627.21521,122.0200AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID111184Percent plasma glucose concentration of drug treated mice (ob/ob) relative to vehicle control animals1992Journal of medicinal chemistry, Mar-06, Volume: 35, Issue:5
Perfluorocarbon-based antidiabetic agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's6 (20.69)18.2507
2000's5 (17.24)29.6817
2010's14 (48.28)24.3611
2020's4 (13.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.62 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.95 (4.65)
Search Engine Demand Index45.20 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]